What Is the First-Line Treatment of an Acute Gout Flare?

Acute gout presents as a sudden, severely painful inflammatory arthritis. Effective management depends on early action — evidence indicates that treatment initiated as soon as possible after flare onset leads to faster resolution of symptoms.

Clinical Situation

An acute gout flare requiring prompt anti-inflammatory treatment. The timing of initiation — particularly within the first hours of symptom onset — is a key determinant of how quickly the flare resolves.

Treatment Goal

Target outcome: Resolution of the acute gout flare with complete relief of joint pain and inflammation.

Approach (partial overview)

First-line management draws on anti-inflammatory agents — the full protocol defines the specific options, the critical timing window, and when a combination approach becomes appropriate for more severe or multi-joint presentations. Complete regimen, agent selection, sequencing, and decision criteria are available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1136/annrheumdis-2016-209707

Recommended first-line options for acute flares are colchicine (within 12 hours of flare onset) at a loading dose of 1 mg followed 1 hour later by 0.5 mg on day 1 and/or an NSAID (plus proton pump inhibitors if appropriate), oral corticosteroid (30-35 mg/day of equivalent prednisolone for 3-5 days) or articular aspiration and injection of corticosteroids.

The task force does not prioritise between these options because of no direct comparative evidence, but unlike 2006 item 4, it recommends considering combination therapy, such as colchicine and an NSAID or colchicine and corticosteroids, which can be proposed for patients with particularly severe acute gout, for instance, when flares involve multiple joints.

Acute flares of gout should be treated as early as possible.

View source ↗